Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Stanbery

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Breast Cancer Research : BCR|January 13, 2012
Steps solidifying a role for SEPT9 in breast cancer suggest that greater strides are neededLaura Stanbery, Elizabeth M Petty
Drug Design, Development and Therapy|October 17, 2017
Assay development and high-throughput screening for small molecule inhibitors of a <i>Vibrio cholerae</i> stress response pathwayLaura Stanbery, Jyl S Matson
International Journal of Molecular Sciences|July 2, 2021
Ovarian Cancer Immunotherapy and Personalized MedicineSusan Morand, Monika Devanaboyina, Hannah Staats, et al.
JNCI Cancer Spectrum|January 7, 2021
<i>BRCA1/2</i> Mutation Status Impact on Autophagy and Immune Response: Unheralded TargetSusan Morand, Laura Stanbery, Adam Walter, et al.
Frontiers in Oncology|November 17, 2022
Systemic benefit of radiation therapy <i>via</i> abscopal effectDaniel J Craig, Stephanie Ambrose, Laura Stanbery, et al.
Cancer Gene Therapy|April 29, 2020
TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trialsKhalil Choucair, Susan Morand, Laura Stanbery, et al.
Future Oncology (London, England)|April 23, 2024
Regulatory role of CD39 and CD73 in tumor immunityNicole Kaplinsky, Kada Williams, Dean Watkins, et al.
Infectious Agents and Cancer|December 9, 2020
FDA efficiency for approval process of COVID-19 therapeuticsChristine Cassidy, Danielle Dever, Laura Stanbery, et al.
Gynecologic Oncology Reports|December 24, 2019
HER2-positive metastatic cervical cancer responsive to first and second-line treatment: A case reportDylan Fortman, Rochell Issa, Laura Stanbery, et al.
Immunotherapy|April 28, 2022
Small-cell breast carcinoma with response to atezolizumab: a case reportNicholas Stimes, Laura Stanbery, Mary Albrethsen, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Breast Cancer Research : BCR|January 13, 2012
Steps solidifying a role for SEPT9 in breast cancer suggest that greater strides are neededLaura Stanbery, Elizabeth M Petty
Drug Design, Development and Therapy|October 17, 2017
Assay development and high-throughput screening for small molecule inhibitors of a <i>Vibrio cholerae</i> stress response pathwayLaura Stanbery, Jyl S Matson
International Journal of Molecular Sciences|July 2, 2021
Ovarian Cancer Immunotherapy and Personalized MedicineSusan Morand, Monika Devanaboyina, Hannah Staats, et al.
JNCI Cancer Spectrum|January 7, 2021
<i>BRCA1/2</i> Mutation Status Impact on Autophagy and Immune Response: Unheralded TargetSusan Morand, Laura Stanbery, Adam Walter, et al.
Frontiers in Oncology|November 17, 2022
Systemic benefit of radiation therapy <i>via</i> abscopal effectDaniel J Craig, Stephanie Ambrose, Laura Stanbery, et al.
Cancer Gene Therapy|April 29, 2020
TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trialsKhalil Choucair, Susan Morand, Laura Stanbery, et al.
Future Oncology (London, England)|April 23, 2024
Regulatory role of CD39 and CD73 in tumor immunityNicole Kaplinsky, Kada Williams, Dean Watkins, et al.
Infectious Agents and Cancer|December 9, 2020
FDA efficiency for approval process of COVID-19 therapeuticsChristine Cassidy, Danielle Dever, Laura Stanbery, et al.
Gynecologic Oncology Reports|December 24, 2019
HER2-positive metastatic cervical cancer responsive to first and second-line treatment: A case reportDylan Fortman, Rochell Issa, Laura Stanbery, et al.
Immunotherapy|April 28, 2022
Small-cell breast carcinoma with response to atezolizumab: a case reportNicholas Stimes, Laura Stanbery, Mary Albrethsen, et al.
Pageof 5